期刊文献+

C-反应蛋白的动态变化对难治性类风湿关节炎的预测价值分析

Analysis of Predictive Value of Dynamic Changes of C-reactive Protein in Refractory Rheumatoid Arthritis
下载PDF
导出
摘要 目的浅析血清CRP(C-反应蛋白)的变化在RRA(难治性类风湿关节炎)临床预测中的价值。方法回顾性2016年1月—2017年1月在浙江萧山医院确诊的100例类风湿关节炎患者作为研究病例,依据甲氨蝶呤片与柳氮磺胺吡啶肠溶片两种药物治疗6个月后的临床疗效,将100例患者随机分为实验组和对照组。其中,药物治疗无效的25例患者纳入实验组,其余75例纳入对照组。检测药物治疗前、治疗后12、16、20、24周的血清CRP含量,并用DAS28值评价患者的疾病活动度。结果药物只治疗24周的随访结果显示,RRA的发生率是25%。药物治疗24周,实验组患者的CRP含量是(14.38±3.88)mg/L,呈现出动态变化,且各时间段的含量均明显高于对照组(P<0.05)。结论实验组RRA患者血清CRP水平随时间推移所呈现出的动态变化,可以在某种程度上作为预测RRA的重要依据。 Objective To analyze the predictive value of dynamic changes of c-reactive protein in refractory rheumatoid arthritis. Meth- ods 100 cases of patients with rheumatoid arthritis diagnosed in our hospital from January 2016 to January 2017 were selected and randomly divided into two groups according to the clinical curative effect after 6-month treatment of methotrexate and sulfasalazine sasp tablets, the experimental group were 25 cases whose drug treatment was ineffective, and the other 75 cases were included into the control group, and the serum CRP contents in 12 weeks, 16 weeks, 20 weeks and 24 weeks after treatment and before treatment were tested and the disease activity degree of patients was evaluated by the DAS28 value. Results The 25-week follow-up results showed that the incidence rate of RRA was 25%, and the CRP content in the experimental group after 24-week drug treatment was (14.38±3.88)rag/L, showing a dynamic change, and the contents in various time phases were obviously higher than those in the con- trol group (P〈0.05). Conclusion As the time goes by, the serum CRP level has a dynamic change of RRA disease patients in the ex- perimental group, which can be used as an important basis of predicting the RRA to a certain degree.
作者 钱慧玲 钱颖玲 周小智 QIAN Hui-ling QIAN Ying-ling ZHOU Xiao-zhi(Department of Rheumatie Immunology Nephropathy, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang Province, 311202 China Department of Rehabilitation, Jian Central People's Hospital, Jian, Jiangxi Province, 343000 China Department of Endocrinology, Jian Central People's Hospital, Jian, Jiangxi Province, 343000 China)
出处 《世界复合医学》 2017年第2期7-9,共3页 World Journal of Complex Medicine
关键词 难治性类风湿关节炎 血清C-反应蛋白 预测价值 动态变化 Refractory rheumatoid arthritis Serum C-reactive protein Predictive value Dynamic change
  • 相关文献

参考文献10

二级参考文献68

  • 1王俊锦,王玲,王其德.综合治疗类风湿关节炎88例[J].中国针灸,2008,28(S1):112-112. 被引量:2
  • 2刘秀明,宫怡,竺红,王革,胡继宏.血清抗肽酰基精氨酸脱亚胺酶4抗体与类风湿关节炎的相关性探讨[J].宁夏医科大学学报,2012,34(3):229-233. 被引量:3
  • 3胡大伟,鲍春德,陈顺乐,古洁若,栗占国,孙凌云,韩星海,倪立青.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗类风湿关节炎双盲随机多中心对照临床研究[J].中华风湿病学杂志,2005,9(11):664-668. 被引量:86
  • 4van de Putte LB,Kroot E J, van Riel PL.Management of refractory rheumatoid arthritis [J]. rheumatology ( Oxford ) ,1999,38 ( 2 ) :32-34.
  • 5中华医学会.临床诊疗指南:风湿病分册[M].北京:人民卫生出版社,2010:1-11.
  • 6Felson DT,Anderson JJ,Boers M,et al.AmericanCollege of Rheumatology Preliminary definition ofimprovement in rheumatoid arthritis [ J ] .Arthritis Rheum,1995,38 ( 6 ) :727-735.
  • 7Feldmann M,Brennan FM,Maini RN. Role of cytokines in rheumatoid arthritis [ J ] .Ann Rev Immunol 1996,14:397-440.
  • 8Genovese MC,Bathon JM,Fleischmann RW, et al.Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis [ J ] . J Rheumatol,2005,32 ( 7 ) :1232-1242.
  • 9Emery P, Breedveld FC,Hall S,et al.Comparison of methotrexate monotherapy with a combination of methotrexate and etenercept in active,early, moderate to severe rheumatoid arthritis (COMET) :a randomized, double-blind,parallel treatment trial [ J ]. Lancet,2008,372 ( 9636 ) :375-382.
  • 10Aletaha D, Neogi T, Silman A J, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collab- orative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部